細胞トランスフェクションの世界市場レポート 2025

細胞トランスフェクション市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.0％で20億米ドルに成長します。予測期間の成長は、遺伝子治療需要の高まり、慢性疾患の有病率の上昇、バイオ医薬品製造の拡大、プロテオミクスとゲノミクス研究の成長、RNAベースの治療薬の用途拡大などに起因しています。予測期間における主な動向としては、バイオテクノロジーおよび医薬品研究開発への投資の増加、トランスフェクション技術の進歩、個別化医療の採用、がん研究におけるトランスフェクションの利用、新規トランスフェクション試薬およびキットの開発などが挙げられます。

感染症の罹患率の上昇が細胞トランスフェクション市場の成長を牽引すると予想されます。感染症は、個人間の接触や汚染された感染源を通じて広がる細菌によって引き起こされ、不十分な公衆衛生インフラ、ワクチン接種のためらい、誤った情報により、より一般的になっています。遺伝子を細胞に導入することで、感染症が細胞にどのような影響を与えるかを理解し、新しい治療法を試すことができるからです。例えば、2023年9月にオーストラリア統計局が発表した報告書によると、インフルエンザおよび肺炎による死亡率は、2021年の10万人当たり31.5人から2022年には42.6人に増加しています。このような感染症患者の増加が、細胞トランスフェクション技術の需要を促進しています。

細胞トランスフェクション市場の主要企業は、遺伝子発現を正確に制御できるよう、トランスフェクション・システムにイノベーションを取り入れています。トランスフェクション・システムは、遺伝子の機能を研究したり、タンパク質を生産したり、遺伝子発現を変更したりするために、外来核酸を細胞に導入します。例えば、2024年7月、カナダのバイオテクノロジー企業であるSTEMCELL Technologies社は、Cellporeトランスフェクション・システムを発表しました。この先進的なツールは、マイクロ流体技術を使って高分子の細胞内への送達を改善し、従来の方法の限界を克服するものです。このシステムは毎秒1,000万個の細胞を扱うことができ、大規模なアプリケーションに適しています。T細胞や造血幹細胞を含む様々な細胞タイプに対応し、低分子、RNA、タンパク質、抗体など様々なタイプのカーゴを送達することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界細胞トランスフェクションPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の細胞トランスフェクション市場：成長率分析
• 世界の細胞トランスフェクション市場の実績：規模と成長, 2019-2024
• 世界の細胞トランスフェクション市場の予測：規模と成長, 2024-2029, 2034F
• 世界細胞トランスフェクション総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の細胞トランスフェクション市場：方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エレクトロポレーション
• リポフェクション
• リン酸カルシウム
• ウイルストランスフェクション
• その他の方法
• 世界の細胞トランスフェクション市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物医学調査
• 治療の送達
• タンパク質生産
• 世界の細胞トランスフェクション市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 学術研究機関
• 製薬およびバイオテクノロジー企業
• 契約調査機関
• その他のエンドユーザー
• 世界の細胞トランスフェクション市場、エレクトロポレーションのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スクエアウェーブエレクトロポレーション
• パルス電界エレクトロポレーション
• マルチ電極アレイ電気穿孔法
• 世界の細胞トランスフェクション市場リポフェクションの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• カチオン性脂質ベースのトランスフェクション
• 脂質ナノ粒子を用いたトランスフェクション
• リポソームトランスフェクション
• 世界の細胞トランスフェクション市場リン酸カルシウムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• リン酸カルシウム共沈
• 改良リン酸カルシウム法
• 世界の細胞トランスフェクション市場ウイルストランスフェクションのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• レンチウイルスの導入
• アデノウイルスの導入
• AAV（アデノ随伴ウイルス）の導入
• 世界の細胞トランスフェクション市場、その他の方法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロインジェクション
• ナノ粒子を介したトランスフェクション
• ソノポレーション
• マグネトフェクション

第7章 地域別・国別分析

• 世界の細胞トランスフェクション市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の細胞トランスフェクション市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞トランスフェクション市場：競合情勢
• 細胞トランスフェクション市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sigma-Aldrich Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Stemcell Technologies Inc.
• GenScript Biotech Corporation
• Promega Corporation
• Takara Bio Inc.
• Molecular Devices LLC
• New England Biolabs Inc.
• CureVac SE
• OriGene Technologies Inc.
• Tocris Bioscience
• Vector Biolabs
• Mirus Bio LLC
• Addgene Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 細胞トランスフェクション市場2029：新たな機会を提供する国
• 細胞トランスフェクション市場2029：新たな機会を提供するセグメント
• 細胞トランスフェクション市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cell transfection is a technique in molecular biology used to introduce nucleic acids such as DNA, RNA, or oligonucleotides into eukaryotic cells. This method enables researchers to investigate gene function, protein expression, and other cellular processes by altering the genetic material of the cells. It is an essential tool in genetic engineering, drug discovery, and various areas of biomedical research.

The main methods of cell transfection include electroporation, lipofection, calcium phosphate, viral transfection, and others. Electroporation involves applying brief electrical pulses to create temporary pores in cell membranes, allowing genetic material or molecules to enter the cell. This technique is used for biomedical research, therapeutic delivery, and protein production by various end users, including academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and others.

The cell transfection market research report is one of a series of new reports from The Business Research Company that provides cell transfection market statistics, including cell transfection industry global market size, regional shares, competitors with a cell transfection market share, detailed cell transfection market segments, market trends and opportunities, and any further data you may need to thrive in the cell transfection industry. This cell transfection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell transfection market size has grown strongly in recent years. It will grow from $1.29 $ billion in 2024 to $1.42 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to surge in CRISPR and gene editing studies, rising funding from governments and non-governmental organizations, increasing clinical trials involving transfected cells, expansion of academic research in molecular biology, growing popularity of high-throughput screening methods.

The cell transfection market size is expected to see strong growth in the next few years. It will grow to $2 $ billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising demand for gene therapy, rising prevalence of chronic diseases, expansion of biopharmaceutical manufacturing, growth in proteomics and genomics research, growing applications of RNA-based therapeutics. Major trends in the forecast period include increasing investment in biotech and pharmaceutical research and development, advancements in transfection technologies, adoption of personalized medicine, use of transfection in cancer research, development of novel transfection reagents and kits.

The rising incidence of infectious diseases is expected to drive the growth of the cell transfection market. Infectious diseases, caused by germs that spread through person-to-person contact or contaminated sources, have become more prevalent due to inadequate public health infrastructure, vaccine hesitancy, and misinformation. Cell transfection is a valuable tool for studying these diseases, as it allows researchers to introduce genes into cells to understand how infections affect them and to test new treatments. For example, a report from the Australian Bureau of Statistics in September 2023 noted that the death rate from influenza and pneumonia increased from 31.5 per 100,000 in 2021 to 42.6 per 100,000 in 2022. This rise in infectious disease cases is fueling the demand for cell transfection technologies.

Leading companies in the cell transfection market are incorporating innovations into their transfection systems to allow for precise control over gene expression. A transfection system introduces foreign nucleic acids into cells to study gene function, produce proteins, or modify gene expression. For instance, in July 2024, STEMCELL Technologies, a Canadian biotechnology firm, introduced the Cellpore transfection system. This advanced tool uses microfluidic technology to improve the delivery of macromolecules into cells, overcoming limitations of traditional methods. The system can handle up to 10 million cells per second and is suitable for large-scale applications. It works with various cell types, including T cells and hematopoietic stem cells, and can deliver different types of cargo, such as small molecules, RNA, proteins, and antibodies.

In July 2023, Sartorius AG, a German provider of pharmaceutical and laboratory equipment, acquired Polyplus-Transfection SA for $2.6 billion (€2.4 billion). This acquisition positions Sartorius and Polyplus as major players in the cell and gene therapies market, combining Sartorius's expertise with Polyplus's leadership in innovative cell transfection solutions. Polyplus-Transfection SA is a French company specializing in cell transfection technologies.

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

North America was the largest region in the cell transfection market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell transfection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell transfection market consists of revenues earned by entities by providing services such as stable cell line development, high-throughput transfection, transient transfection services and viral vector production. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell transfection market also includes sales of reagents, kits, electroporation systems and other related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Transfection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell transfection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell transfection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell transfection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Method: Electroporation; Lipofection; Calcium Phosphate; Viral Transfection; Other Methods
• 2) By Application: Biomedical Research; Therapeutic Delivery; Protein Production
• 3) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Other End Users
• Subsegments:
• 1) By Electroporation: Square Wave Electroporation; Pulsed Electric Field Electroporation; Multielectrode Array Electroporation
• 2) By Lipofection: Cationic Lipid-Based Transfection; Lipid Nanoparticle-Based Transfection; Liposomal Transfection
• 3) By Calcium Phosphate: Calcium Phosphate Co-precipitation; Modified Calcium Phosphate Methods
• 4) By Viral Transfection: Lentiviral Transduction; Adenoviral Transduction; AAV (Adeno-Associated Virus) Transduction
• 5) By Other Methods: Microinjection; Nanoparticle-Mediated Transfection; Sonoporation; Magnetofection
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; Lonza Group AG; Sartorius AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Transfection Market Characteristics

3. Cell Transfection Market Trends And Strategies

4. Cell Transfection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell Transfection Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell Transfection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell Transfection Market Growth Rate Analysis
• 5.4. Global Cell Transfection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell Transfection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell Transfection Total Addressable Market (TAM)

6. Cell Transfection Market Segmentation

• 6.1. Global Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electroporation
• Lipofection
• Calcium Phosphate
• Viral Transfection
• Other Methods
• 6.2. Global Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biomedical Research
• Therapeutic Delivery
• Protein Production
• 6.3. Global Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations
• Other End Users
• 6.4. Global Cell Transfection Market, Sub-Segmentation Of Electroporation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Square Wave Electroporation
• Pulsed Electric Field Electroporation
• Multielectrode Array Electroporation
• 6.5. Global Cell Transfection Market, Sub-Segmentation Of Lipofection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cationic Lipid-Based Transfection
• Lipid Nanoparticle-Based Transfection
• Liposomal Transfection
• 6.6. Global Cell Transfection Market, Sub-Segmentation Of Calcium Phosphate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcium Phosphate Co-precipitation
• Modified Calcium Phosphate Methods
• 6.7. Global Cell Transfection Market, Sub-Segmentation Of Viral Transfection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lentiviral Transduction
• Adenoviral Transduction
• AAV (Adeno-Associated Virus) Transduction
• 6.8. Global Cell Transfection Market, Sub-Segmentation Of Other Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microinjection
• Nanoparticle-Mediated Transfection
• Sonoporation
• Magnetofection

7. Cell Transfection Market Regional And Country Analysis

• 7.1. Global Cell Transfection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell Transfection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Transfection Market

• 8.1. Asia-Pacific Cell Transfection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Transfection Market

• 9.1. China Cell Transfection Market Overview
• 9.2. China Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Transfection Market

• 10.1. India Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Transfection Market

• 11.1. Japan Cell Transfection Market Overview
• 11.2. Japan Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Transfection Market

• 12.1. Australia Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Transfection Market

• 13.1. Indonesia Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Transfection Market

• 14.1. South Korea Cell Transfection Market Overview
• 14.2. South Korea Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Transfection Market

• 15.1. Western Europe Cell Transfection Market Overview
• 15.2. Western Europe Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Transfection Market

• 16.1. UK Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Transfection Market

• 17.1. Germany Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Transfection Market

• 18.1. France Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Transfection Market

• 19.1. Italy Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Transfection Market

• 20.1. Spain Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Transfection Market

• 21.1. Eastern Europe Cell Transfection Market Overview
• 21.2. Eastern Europe Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Transfection Market

• 22.1. Russia Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Transfection Market

• 23.1. North America Cell Transfection Market Overview
• 23.2. North America Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Transfection Market

• 24.1. USA Cell Transfection Market Overview
• 24.2. USA Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Transfection Market

• 25.1. Canada Cell Transfection Market Overview
• 25.2. Canada Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Transfection Market

• 26.1. South America Cell Transfection Market Overview
• 26.2. South America Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Transfection Market

• 27.1. Brazil Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Transfection Market

• 28.1. Middle East Cell Transfection Market Overview
• 28.2. Middle East Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Transfection Market

• 29.1. Africa Cell Transfection Market Overview
• 29.2. Africa Cell Transfection Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell Transfection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell Transfection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Transfection Market Competitive Landscape And Company Profiles

• 30.1. Cell Transfection Market Competitive Landscape
• 30.2. Cell Transfection Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Cell Transfection Market Other Major And Innovative Companies

• 31.1. Sigma-Aldrich Corporation
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. QIAGEN N.V.
• 31.4. Stemcell Technologies Inc.
• 31.5. GenScript Biotech Corporation
• 31.6. Promega Corporation
• 31.7. Takara Bio Inc.
• 31.8. Molecular Devices LLC
• 31.9. New England Biolabs Inc.
• 31.10. CureVac SE
• 31.11. OriGene Technologies Inc.
• 31.12. Tocris Bioscience
• 31.13. Vector Biolabs
• 31.14. Mirus Bio LLC
• 31.15. Addgene Inc.

32. Global Cell Transfection Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Transfection Market

34. Recent Developments In The Cell Transfection Market

35. Cell Transfection Market High Potential Countries, Segments and Strategies

• 35.1 Cell Transfection Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell Transfection Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell Transfection Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer